Latest Breaking News On - Gi gu oncology panel discussion - Page 1 : comparemela.com

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug.

Joyce allaireJames levineCardiff oncology incGi gu oncology panel discussionPrnewswire cardiff oncology incHealth care conferenceAnnual health care conferenceBoston marriott copley placeCardiff oncologyOncology contact